Active ingredientBepotastine BesylateCat. No. P-B051-001CAS 190786-44-8Family · Pharmaceutical analytical standards
Bepotastine
A second-generation H1 antihistamine developed in Japan, where it has been used since 2000 for allergic rhinitis and since 2002 for urticaria and itching; as eye drops it has been approved in the United States since 2009 for allergic conjunctivitis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Besides blocking H1 receptors, it curbs the release of histamine from mast cells, the immune cells that keep it in store.
Go to the active ingredient →Active ingredientBepotastine BesylateCat. No. P-B051-001CAS 190786-44-8
Isotopically labelledBepotastine-d6Cat. No. P-B051-002CAS 2469626-70-6
Isotopically labelledRac-Bepotastine-d6Cat. No. P-B051-003
Impurity(R)-BepotastineCat. No. P-B051-004CAS 190730-41-7
Impurity(R)-Bepotastine BesylateCat. No. P-B051-005CAS 190730-42-8
ImpurityBepotastine Impurity ACat. No. P-B051-006CAS 201594-84-5
ImpurityBepotastine Impurity A TartrateCat. No. P-B051-007CAS 210095-58-2
ImpurityBepotastine Ethyl Ester BesylateCat. No. P-B051-008CAS 190730-39-3
ImpurityBepotastine Impurity 1Cat. No. P-B051-009
ImpurityBepotastine Impurity 2Cat. No. P-B051-010
ImpurityBepotastine Impurity 3Cat. No. P-B051-013
ImpurityBepotastine Impurity 4Cat. No. P-B051-014
ImpurityBepotastine Isopropyl EsterCat. No. P-B051-015CAS 1807607-93-7
ImpurityBepotastine N-Oxide ImpurityCat. No. P-B051-016No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.